Plozalizumab
CAS: 1610761-46-0
Ref. TM-T77118
| 1mg | 345.00 € | ||
| 5mg | 921.00 € | ||
| 10mg | 1,456.00 € | ||
| 25mg | 2,160.00 € | ||
| 50mg | 2,920.00 € | ||
| 100mg | 3,940.00 € |
Estimated delivery in United States, on Friday 25 Oct 2024
Product Information
Name:
Plozalizumab
Synonyms:
- MLN-1202
- hu1D9
- Immunoglobulin G1, anti-(human CC chemokine receptor CCR2) (human-Mus musculus monoclonal 1D9 heavy chain), disulfide with human-Mus musculus monoclonal 1D9 κ-chain, dimer
Description:
Plozalizumab (MLN-1202) is a humanized selective and potent anti-CCR2 antibody.Plozalizumab has antitumor activity.Plozalizumab is used in the study of
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
96.4%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T77118 Plozalizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
